These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Functional efficiency of antitumor cytotoxic lymphoid cells. Wunderlich JR; Martin WJ; Macdonald J Isr J Med Sci; 1973 Mar; 9(3):317-23. PubMed ID: 4710039 [No Abstract] [Full Text] [Related]
27. Effect of pregnancy on the reactions of lymphocytes with cytotoxic antisera. Taylor PA; Rachkewich RA; Gare DJ; Falk JA; Shumak KH; Crookston MC Transplantation; 1974 Jan; 17(1):142-6. PubMed ID: 4855590 [No Abstract] [Full Text] [Related]
28. The time of onset of placental susceptibility in mice to heterologous anti-mouse placental serum. Kometani K; Behrman SJ Int J Fertil; 1971; 16(3):139-43. PubMed ID: 4331593 [No Abstract] [Full Text] [Related]
29. The immunologic specificity and biologic activity of heterologous anti-human sera. I. Properties of rabbit anti-human fibroblast sera. Bachvaroff R; Rapaport FT J Immunol; 1972 Nov; 109(5):1081-9. PubMed ID: 4627932 [No Abstract] [Full Text] [Related]
30. Gross reactivity between synthetic T,GA-L and transplantation antigens in CBA Mice. Ebringer A; Davies DA Nat New Biol; 1973 Jan; 241(109):144-7. PubMed ID: 4121713 [No Abstract] [Full Text] [Related]
31. Antigenic modulation as a mechanism for tumor escape from immune destruction: identification of modulation-positive and modulation-negative mouse lymphomas with xenoantisera to murine leukemia virus gp70. Stackpole CW; Cremona P; Leonard C; Stremmel P J Immunol; 1980 Oct; 125(4):1715-23. PubMed ID: 6251136 [No Abstract] [Full Text] [Related]
33. Comparison of in vitro effects of anti-skin serum with anti lymphocyte serum. Cohen M; Nelken D Clin Exp Immunol; 1973 Mar; 13(3):417-21. PubMed ID: 4701744 [TBL] [Abstract][Full Text] [Related]
34. Fetal antigens shared as transplantation rejection antigens on chemically induced mouse and hamster sarcomas. Coggin JH; Adkinson L; Anderson NG Cancer Res; 1980 May; 40(5):1568-73. PubMed ID: 6768448 [No Abstract] [Full Text] [Related]
35. Further evidence for the role of macrophages in the initiation of lymphocyte trapping. Frost P Immunology; 1974 Oct; 27(4):609-16. PubMed ID: 4140147 [TBL] [Abstract][Full Text] [Related]
36. The protective effect of antisera against leukaemia in vivo--a reappraisal. Hersey P Br J Cancer Suppl; 1973 Aug; 1():11-8. PubMed ID: 4807573 [TBL] [Abstract][Full Text] [Related]
37. Description of a murine B lymphoma tumor-specific antigen. Koch S; Zalcberg JR; McKenzie IF J Immunol; 1984 Aug; 133(2):1070-7. PubMed ID: 6203965 [TBL] [Abstract][Full Text] [Related]
38. [Current and prospective problems in tumor immunology]. Pitzurra M Boll Ist Sieroter Milan; 1971; 50(3):209-20. PubMed ID: 4947785 [No Abstract] [Full Text] [Related]
39. The cytolytic activity of human lymphocytes. I. Cytolytic activity towards PPD-coated target cells in tuberculin positive and negative individuals. Rehn TG; Henney CS Johns Hopkins Med J; 1972 Oct; 131(4):261-70. PubMed ID: 5081728 [No Abstract] [Full Text] [Related]
40. [Protection against runting disease by immunologic facilitation (enhancement phenomenon) induced passively and actively]. Voisin GA; Kinsky R; Maillard J Ann Inst Pasteur (Paris); 1967 Oct; 113(4):521-47. PubMed ID: 6057335 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]